Opioids and opiates: analgesia with cardiovascular, haemodynamic and immune implications in critical illness.
Traumatic injury, surgical interventions and sepsis are amongst some of the clinical conditions that result in marked activation of neuroendocrine and opiate responses aimed at restoring haemodynamic and metabolic homeostasis. The central activation of the neuroendocrine and opiate systems, known collectively as the stress response, is elicited by diverse physical stressor conditions, including ischaemia, glucopenia and inflammation. The role of the hypothalamic-pituitary-adrenal axis and sympathetic nervous system in counterregulation of haemodynamic and metabolic alterations has been studied extensively. However, that of the endogenous opiates/opioid system is still unclear. In addition to activation of the opiate receptor through the endogenous release of opioids, pharmacotherapy with opiate receptor agonists is frequently used for sedation and analgesia of injured, septic and critically ill patients. How this affects the haemodynamic, cardiovascular, metabolic and immune responses is poorly understood. The variety of opiate receptor types, their specificity and ubiquitous location both in the central nervous system and in the periphery adds additional complicating factors to the clear understanding of their contribution to the stress response to the various physical perturbations. This review aims at discussing scientific evidence gathered from preclinical studies on the role of endogenous opioids as well as those administered as pharmacological agents on the host cardiovascular, neuroendocrine, metabolic and immune response mechanisms critical for survival from injury in perspective with clinical observations that provide parallel assessment of relevant outcome measures. When possible, the clinical relevance and corresponding scenarios where this evidence can be integrated into our understanding of the clinical implications of opiate effects will be examined. Overall, the scientific basis to enhance clinical judgment and expectations when using opioid sedation and analgesia in the management of the injured, septic or postsurgical patient will be discussed.
Molina
P E
PE
Department of Physiology, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA. pmolin@lsuhsc.edu
D000701:Analgesics, Opioid / Q000627:therapeutic use; D002319:Cardiovascular System / Q000378:metabolism; D016638:Critical Illness; D006801:Humans; D009294:Narcotics / Q000627:therapeutic use*; D015213:Neuroimmunomodulation; D009490:Neurosecretory Systems / Q000502:physiology; D018847:Opioid Peptides / Q000378:metabolism*; D010146:Pain / Q000188:drug therapy*; D011957:Receptors, Opioid / Q000378:metabolism*; D013312:Stress, Physiological / Q000378:metabolism; D014947:Wounds and Injuries / Q000150:complications / Q000378:metabolism
D000701:Analgesics, Opioid; D009294:Narcotics; D018847:Opioid Peptides; D011957:Receptors, Opioid